HALO AP

Indica Labs Receives FDA Clearance for HALO AP Dx Digital Pathology Platform for Use with Hamamatsu Images Acquired with the NanoZoomer® S360MD Slide Scanner

Albuquerque, NM, and Hamamatsu City, Japan – 22 May, 2024 – Indica Labs, an industry leader in AI-powered digital pathology solutions, and Hamamatsu Photonics K.K., a pioneer in whole slide imaging systems, announce that the U.S. Food and Drug Administration (FDA) has issued a 510(k) clearance to Indica Labs for HALO AP Dx, an enterprise digital pathology platform.

Indica Labs Receives FDA Clearance for HALO AP Dx Digital Pathology Platform for Use with Hamamatsu Images Acquired with the NanoZoomer® S360MD Slide Scanner Read More »

AI-based Slide Quality Control Workflows for Life Science and Clinical Applications

18 April 2024 | In this 1-hour webinar learn about SlideQC BF 3.0, an AI-based image quality control network that detects and segments most common artifacts including air bubbles, debris, folds, out of focus regions, and pen marker in both hematoxylin and eosin (H&E) and immunohistochemistry (IHC) images.

AI-based Slide Quality Control Workflows for Life Science and Clinical Applications Read More »

HALO Macrodissection Solutions: Enhancing the Accuracy of Personalized Oncology Through AI-Powered Slide Macrodissection

Lung Macrodissect AI identifies and highlights non-small cell lung cancer cells present on whole slide images to guide annotations for downstream automated slide macrodissection.

HALO Macrodissection Solutions: Enhancing the Accuracy of Personalized Oncology Through AI-Powered Slide Macrodissection Read More »

Towards Open Pathology: Facilitating Development of Novel AI-based Tools for Digital Pathology through Collaboration and Integration

16 October 2022 | In this 1-hour workshop, Eric Runde, Chief Operating Officer at Indica Labs, will introduce Indica’s platforms, our collaborative approach to incorporating artificial intelligence (AI) into life science and clinical workflows, and the open pathology tools available to developers and industry partners. Dr. Peter Caie, Principal Scientist of AI Collaborations at Indica Labs, will present case studies of customer collaborations resulting in the development and validation of commercially available and inter-operable AI algorithms addressing customer needs.

Towards Open Pathology: Facilitating Development of Novel AI-based Tools for Digital Pathology through Collaboration and Integration Read More »

Adoption of the HALO® Platform at Caris Life Sciences’ High Volume Digital Pathology Laboratory

17 October 2021 | In this one-hour pre-conference workshop, Indica Labs is pleased to host Dr. Matthew Oberley, Executive Medical Director at Caris Life Sciences, who will present a case study on deploying HALO AP® case management software in their high-volume, fully digital, anatomic pathology lab. Dr. Oberley will discuss the challenges and selection criteria that led to the adoption of HALO AP, describe the integration into their laboratory workflows, and, finally, touch on the rollout progress and future plans to utilize HALO and HALO AI.

Adoption of the HALO® Platform at Caris Life Sciences’ High Volume Digital Pathology Laboratory Read More »

Looking Back: Reviewing 2023 at Indica Labs

As we welcome the new year and look back on 2023, the Indica Labs team wants to extend our heartfelt thanks to our customers and collaborators. We feel privileged to have been a part of our customers’ impactful contributions in the lab and clinic, and it is thrilling to hear of their successes improving patient care as well as our understanding and treatment of disease.

Looking Back: Reviewing 2023 at Indica Labs Read More »

Scroll to Top